Chisato M Yamazaki

7PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 02, 2025
A cytotoxic peptide-drug conjugate for tumor-specific delivery of co-injected molecules.

Norio Miyamura, Chisato M Yamazaki, Yasuaki Anami

|Mar 07, 2025
177Lu-Labeled Antibody-Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors.

Aiko Yamaguchi, Chisato M Yamazaki, Yasuaki Anami

|Jul 06, 2022
An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates.

Summer Y Y Ha, Yasuaki Anami, Chisato M Yamazaki

|Apr 15, 2022
Homogeneous antibody-angiopep 2 conjugates for effective brain targeting.

Yasuaki Anami, Wei Xiong, Aiko Yamaguchi

|Jun 11, 2021
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance.

Chisato M Yamazaki, Aiko Yamaguchi, Yasuaki Anami

|Sep 04, 2020
LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia.

Yasuaki Anami, Mi Deng, Xun Gui

Pageof 2